First the role of micronutrients was indicated by experimental studies. In 1932 Hale [1] demonstrated that during early pregnancy in sows a diet free of vitamin A resulted in offspring without eyeballs, i.e. anophthalmia. Later the introduction of antimetabolites made possible the conversion of long-term nutritional experiments into short-term chemical tests, e.g. folate deficiency caused by antimetabolites of folic acid was proved to be highly teratogenic both in pregnant rats [2] and women [3] . In addition, human epidemiological studies showed an obvious socioeconomic status dependence of some CAs, e.g. the risk of neural-tube defects (NTDs) was found to increase from a low risk in the highest class to an above-average risk in the lowest class in the UK and some other countries [4] . On the basis of these data, Smithells et al. [5] hypothesized that, among triggering environmental factors in the origin of NTDs, undernutrition could be the common denominator. Actually a lower concentration of red-cell folate and vitamin C was found during the first trimester of pregnancy in women who later gave birth to an infant with a NTD than in matched controls [5] . After this, Smithells et al. [6] organized the first intervention study to check the efficacy of a multivitamin containing folic acid for the reduction of recurrent NTDs. A disturbance in the closure of the neural tube, i.e. NTD, occurs between postconceptional days 15 and 28, thus most women are unaware of their pregnancy during the so-called critical period for the development of a NTD. The supplementation of multivitamins (table 1) was commenced therefore at least 28 days prior to conception and continued at least to the 6th postconceptional week in women who had previously had NTD infants, while controls who had also previously had NTD infants were not supplemented during the periconceptional period. A 91 and 83% reduction in NTD recurrence was found in the Yorkshire region of the UK [6] and Northern Ireland [7] , respectively. However, their findings were not accepted by some experts because of the possible social selection in this non-randomized clinical trial. In the early 1980s therefore the Medical Research Council in the UK decided to organize a multicenter randomized double-blind trial (43% of participants came from Hungary) in women who had already had infants with an NTD [8] pharmacological dose (4 mg) of folic acid alone can reduce NTD recurrence by 71%.
The Hungarian Trials
There were three major questions following the publication of the 'recurrence' studies and our Hungarian randomized, double-blind controlled trial attempted to provide data to answer these questions.
The first question was: 'Does the supplementation of a folic acid-containing multivitamin also reduce the risk of the first occurrence of NTD?' About 95% of women who deliver infants with NTDs have no previous NTD pregnancies, thus one of the critical goals of the Hungarian trial was to determine the Birth Defect Prevention and Micronutrients efficacy of this method in the reduction of the first occurrence of NTD because it is an important public health issue. The second question was connected with the dose. A pharmacological dose (Ͼ1 mg) of folic acid is produced for patients, thus 4 mg may have some adverse effects therefore cannot be recommended for the population at large without medical supervision. The Hungarian trial therefore tested the preventive effect of a physiological dose (0.8 mg) of folic acid as one component of a micronutrient combination (table 1) .
The introduction of a new primary preventive method in the periconceptional period of the healthy female population requires knowledge of all the possible adverse and beneficial effects of a periconceptional micronutrient supplementation, and this was the third question.
The participants in the Hungarian periconceptional care program [9] took part voluntarily in a randomized controlled trial (RCT) between 1984 and 1992 [10] , and later in the two-cohort controlled study (TCS) between 1993 and 1996 [11] . The women were periconceptionally supplemented with the same multivitamin (table 1) , and each was matched with a control pregnant woman, not supplemented with multivitamin, folic acid or other micronutrient during the periconceptional period, from regional prenatal care clinics in the TCS.
The results of these two intervention trials are shown in table 2 with regard to the primary prevention of a first occurrence of NTDs. The pooled findings of these trials indicate that approximately 92% of the first occurrence of NTDs may be prevented using a micronutrient, i.e. multivitamin, mineral, Birth Defect Prevention and Micronutrients trace element combination containing a physiological dose (0.8 mg) of folic acid during the periconceptional period.
Another important finding of the RCT is related to the third question because a significant reduction was found in the total (birth ϩ fetal) prevalence of CAs (20.64/1,000 in the supplemented and 40.57/1,000 in the unsupplemented group, i.e. OR 0.53 with 95% CI 0.35, 0.70) and this cannot be explained by the reduction in NTD offspring [12] . The total reduction in CAs without NTD cases was 19.93/1,000 which exceeded the total prevalence of NTD (2.78/1,000) in Hungary by 7.2-fold. Isolated CAs of the urinary tract and cardiovascular system also showed a significant decrease while the occurrence of limb reduction CAs was somewhat but not significantly lower (table 3) [13] . On the other hand there was no preventive effect for orofacial clefts and multiple CAs.
The main goal of the TCS was to differentiate the chance and micronutrientdependent effect of periconceptional micronutrient supplementation in the prevention of the above-mentioned candidate CAs and to identify specific preventable types within these CA groups. The findings of the TCS partly confirmed the previous results of the RCT because a significant reduction was found in the group of cardiovascular CAs particularly for ventricular septal defects. The reduction in urinary tract CAs did not reach the level of significance, but the obstructive CAs of the pelvic-ureter junction showed a significant decrease in agreement with the findings of the RCT. The number of offspring was not enough to evaluate limb reduction CAs and our results again did not show prevention of isolated orofacial clefts. In addition recent US observational studies confirmed our results regarding the preventive effect of periconceptional micronutrient supplementation containing folic acid on CAs of the urinary tract [14, 15] , cardiovascular system [16, 17] and limbs [15, 16, 18] .
In conclusion, recent data provide encouragement for the concept that a considerable proportion of major CAs -beyond NTDs -are preventable by micronutrients containing folic acid.
Mechanism of Prevention
Different CAs have different etiologies therefore different mechanisms can be supposed for the prevention of CAs by micronutrients. Here only the possible relation between folic acid/folate deficiency and NTDs is highlighted.
Folic acid and folate are different forms of the same vitamin discovered by Wills [19] in 1931. The naturally occurring polyglutamate was named 'folate' while the synthetic monoglutamate was named 'folic acid'. The use of these two names for the same vitamin is confusing, and recently the suggestion was made to introduce the joint term vitamin B 11 for both (in France the term vitamin B 9 is used). There is some evidence supporting the role of hyperhomocysteinemia in the origin of some NTDs.
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(a) Four B vitamins are involved in the homocysteine and folate metabolism ( fig. 2 ). When proteins of meat, fish or plants are digested, amino acids, including methionine, are released. During the conversion of methionine to cysteine, the metabolite homocysteine is formed. In humans, homocysteine is toxic above a certain level, and should therefore be neutralized as soon as possible in some pathways. One of them is the remethylation of homocysteine back to methionine and it is catalyzed by methionine synthase which requires vitamin B 12 as a cofactor and a methyl group. The latter is donated by folate metabolism due to methylenetetrahydrofolate reductase (MTHFR) regulated by the MTHFR gene. The MTHFR gene is located in the short arm of chromosome 1 and a mutation of its codon 677 (cytosine→thymine) causes a thermolabile variant of MTHFR with a significant reduction (50-70%) in enzyme activity [20] and too low a quantity of the methyl group. The consequence is hyperhomocysteinemia.
(b) Mothers who give birth to a child with a NTD have mildly elevated blood and moderately elevated amniotic levels of homocysteine [21] .
(c) Hyperhomocysteinemia and/or a lack of methionine can induce NTDs in animal experiments [22] .
(d) Low maternal folate status appears to be a risk factor for NTDs [5] . (e) Folic acid-folate and vitamin B 12 are able to reduce hyperhomocysteinemia-related NTDs [10, 11] .
The frequency of MTHFR gene polymorphism varies in different populations, with allele frequency ranging from Ͻ10% in some groups of sub-Saharan Africans to 40% in Hispanics in California and in Italians, and 55% in northern Chinese people. The proportion of homozygotes (T/T) and heterozygotes (C/T) is 11 and 45% in the Hungarian population, respectively.
In conclusion, the available data suggest that the cause of NTDs and other CAs is not a primary lack of folate and other micronutrients in the diet. The explanation is an interaction between genetic predisposition caused by inborn errors of folate and/or homocysteine metabolism and nutritional deficiency, because the latter trigger the genetic predisposition. On the other hand a good diet rich in folate and other micronutrients can limit the genetic predisposition caused by MTHFR gene polymorphism, and it may explain the low incidence of NTDs in the infants of couples with higher education and class.
Three Options
Currently there are three options to ensuring appropriate micronutrient consumption in women of childbearing age. All three choices should be pursued in parallel to provide options for women of childbearing age because each of them has different disadvantages and social feasibilities.
Diet Rich in Micronutrients
This option seems to be optimal; however, a NTD is caused by the interaction of genetic predisposition and folate deficiency. The latter is significant in Hungary and most countries because the usual daily intake of folate is 0.18-0.23 mg [23] while the optimal daily intake would be 0.66 for the prevention of NTDs [24] . It is difficult to imagine a 2.9-to 3.7-fold increase in consumption through food intake alone, since this would require about 15 daily servings of spinach or broccoli. In addition a large increase in the consumption of extra folate from natural foods is relatively ineffective at increasing blood folate levels [25] . Thus a diet rich in micronutrients and particularly folate is important in the prevention of NTDs and other CAs, but cannot alone neutralize the genetic predisposition for these CAs.
Periconceptional Supplementation
Capsules containing folic acid and other micronutrients are also appropriate because, e.g., the absorption of folic acid in the gastrointestinal tract is quick and easy. However, in many countries a large proportion of pregnancies (between 10 and 90%) are unplanned, and therefore these women cannot use this new primary preventive method during preconceptional period. On the Birth Defect Prevention and Micronutrients other hand the use of periconceptional micronutrient folic acid needs a strong and widespread educational campaign.
In addition, there is no consensus in the official recommendations concerning the type of supplementation and the dose of micronutrients. In 1992 the US Public Health service recommended that all women who are capable of becoming pregnant should consume 0.4 mg folic acid/day to prevent NTDs [26] . However, there are some arguments against the US recommendation.
(a) The use of micronutrients containing folic acid in two Hungarian trials [10, 11] and the studies of Smithells et al. [6, 7] show a higher efficacy (about 90%) than the Medical Research Council Vitamin Study using a high dose of folic acid alone (about 70%) for the prevention of NTDs.
(b) Folic acid-containing micronutrients seem to be effective in the reduction of urinary tract, cardiovascular and limb reduction CAs, but there are no data concerning a similar preventive effect of folic acid alone for other CAs beyond NTDs.
(c) Hyperhomocysteinemia may play some role in the origin of some NTDs and vitamin B 12 is an important cofactor in the folate-homocysteine metabolism and is an independent risk factor in the origin of NTDs [27] .
The dose of folic acid and vitamin B 12 is also debated. Daly et al. [28] did not find a dose-dependent preventive effect of folic acid for NTDs in their study, while Wald et al. [29] supposed a dose-dependent relation between folic acid and the preventable part of NTDs in their theoretical calculation. However, the upper tolerable dose of folate-folic acid for healthy persons including pregnant women is 1 mg. There is no vitamin B 12 deficiency in Hungary and industrialized countries; however, the major concern about higher doses of folic acid is its so-called masking effect in patients with pernicious anemia. Thus, the combined use of folic acid and vitamin B 12 can prevent this possible adverse effect but only 1-3% of an oral dose of vitamin B 12 can be absorbed from the gastrointestinal tract, therefore a higher dose (e.g. 25 or 100 g) of vitamin B 12 is needed for this purpose instead of the usual low doses (in general 4 g).
Food Fortification
Food fortification seems to be the most practical means of supplementation with folic acid and other micronutrients for women with unplanned pregnancies. This public health initiative is comparable to the prevention of goiter by the addition of iodine to salt. In February 1996, the US Department of Health and Human Service ordered that as of January 1998 flour be fortified with folic acid at a level of 0.14 mg/100 g [30] . Though this adds only about 0.1 mg folic acid to the average daily diet of women of reproductive age, the mean plasma folate concentration increased from 4.6 to 10.0 mg/l and the prevalence of a low folate level (Ͻ3 mg/l) decreased from 20.0 to 1.7%. In addition, the mean total homocysteine concentration decreased from 10.1 to Birth Defect Prevention and Micronutrients 9.4 mol/l and the prevalence of a high homocysteine concentration (Ͼ13 mol/l) decreased from 18.7 to 9.8% [31] . In Hungary three vitamins, folic acid (160 g) and vitamins B 12 (0.8 g) and B 6 (864 g), have been added to bread since August 1998 [32] . A daily intake of 200 g folic acid resulted in an estimated reduction in the risk of NTDs of 41% [28] .
The consumption of bread fortified with folic acid and other vitamins is especially important for a large proportion of women with poor education and low income who in general have unplanned pregnancies. Another goal of this food fortification is the prevention of hyperhomocysteinemia-related coronary artery, cerebrovascular and peripheral vascular diseases. However, it is necessary to change the conservative regulation concerning food fortification with folic acid (e.g. 0.35 mg/100 g flour would result in a much better benefit-cost ratio) and vitamin B 12 (e.g. 25 g can prevent the possible adverse effect of a high dose of folic acid in patients with pernicious anemia).
Conclusions
Diet supplementation with folic acid and other micronutrients in the periconceptional period offers a breakthrough in the primary prevention of NTDs and some other CAs. Obviously primary prevention is better than secondary prevention (i.e. termination of pregnancy after the diagnosis of serious fetal defects) since in addition to excluding the moral and ethical problems and reducing the grief associated with the loss of fetus, primary prevention decreases medical costs.
Discussion
Dr. Beard: Can you give me a few more details about how you enroll your mothers or potential mothers into these preconceptional trials?
Dr. Czeizel: The Hungarian periconceptional care was established in 1984 as a model until 1988 and since then the periconceptional service has been part of the primary health care system. I have to tell you that during the communist regime we had obligatory premarital medical counselling which was very ineffective and very Birth Defect Prevention and Micronutrients unpopular. We wanted to suggest a better alternative in 1984. However, the change in our political system in 1989 was not very good for this system because now everything is facultative. We wanted to achieve a 50% rate in potential parental couples until 2000 but in reality we were only able to enroll 18% of Hungarian couples as participants in the periconceptional service. We have a media propaganda campaign and we have a school subject entitled 'Preparing for family life', thus the young generation is educated on how to prepare for health in pregnancy and a healthy baby. In addition, we have a good connection with medical doctors and mainly regional social nurses because they are very closely connected to Hungarian families.
There are three eligibility criteria: not yet pregnant; no infertility, and voluntary facultative participation. Potential mothers of the randomized controlled trial and twocohort controlled study were enrolled from the participants in the periconceptional service [1] . During these two studies we were able to supply these women with the same type of micronutrient combination including 0.8 mg folic acid free of charge (it is no longer free of charge). In general in the first 4 years we had 2,000 couples in the Budapest center; later we had 15,000-20,000 couples in 32 centers of the whole country because Hungary now has about 100,000 births/year. This periconceptional service is based on three steps. The first step is the check up of reproductive health. If somebody wants to learn to drive it is necessary to check his/her health status. Producing a baby is a very important task and it is good to check the reproductive health of both the potential mothers and fathers. The second step is a 3-month preparatory period for conception and the periconceptional supplementation of the micronutrient combination is part of this protocol. The third step is better protection for early pregnancy because it is a serious paradox of the health system that pregnant women -'good' pregnant women -visit antenatal clinics in about the 8th-9th weeks of gestation, and I showed you a 10-week fetus who is over the body-and organ-forming period. Thus pregnant women visit the antenatal clinic after the most vulnerable period of fetal development and during this 'risky' time the embryo is not protected. Our system is appropriate for this because after the 3-month preparation period we suggest that pregnancy is achieved as soon as possible, and that the mother visits the clinic immediately after the first missed menstrual period, that is in the 3rd postconceptional week. There are sensitive pregnancy tests and ultrasound scanning by which we can diagnose pregnancy. On the other hand we can detect ectopic pregnancies and then conservative treatment can be used. In addition we can diagnose twins. It is very strange, about 6% of early pregnancies are twins but the proportion of twins is only 1% at birth. Our periconceptional service is conducted by qualified nurses, not medical doctors. Medical doctors are too expensive and it is a very time-consuming procedure including the preconceptional screening process. Qualified nurses are appropriate to select women for secondary care.
Dr. Endres: In the past I did not understand why there was a difference in the preventive dosage. So you remember that in the past it was at 4 mg for recurrent cases and 0.4 mg, 1/10th only, for those who have not already given birth to an infant with a neural tube defect (NTD). So I am happy to see that now apparently you do not make this differentiation anymore and you say 1 mg, 0.2 from the diet and in addition 0.8 from whatever.
Dr. Czeizel: I am sorry to interrupt you. I was informed that in New Zealand the recommended dose is 5 mg for healthy women [2] . 4 mg was used by the Medical Research Council (MRC) vitamin study [3] because of the historical background. A previous study by Laurence et al. [4] in Wales used 4 mg of folic acid, but they did not have an appropriate number of cases to achieve the level of significance. I think the MRC experts wanted to continue this approach.
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Dr. Endres: This recommendation was taken over in many countries. I did not understand why in a woman who had already given birth to an infant with NTD, it is taken more seriously than in a woman who has not.
Dr. Czeizel: I agree with you, our micronutrient combination containing 0.8 mg of folic acid was able to prevent both occurrence and recurrence of NTD. However, some experts supposed that recurrent NTD had a stronger genetic predisposition because the risk for NTD occurrence is 0.3% in Hungary while the recurrence risk is ten-times higher after a previous NTD-offspring.
Dr. Endres: What about the discussions of various enzyme activities in the methionine synthesis, in particular of the thermolabile tetrahydrofolate reductase activities?
Dr. Czeizel: I think the major and very exceptional conclusion is that now we are able to prevent a major part of some groups of congenital abnormalities like NTDs, but really we cannot explain this because only 20% of NTDs are caused by hyperhomocysteinemia due to the lower activity of methylenetetrahydrofolate reductase (MTHFR), explained by the gene polymorphism of the MTHFR gene. It appears that about 10% of European people are homozygote and about 40% are heterozygote for this MTHFR gene [5] . This means that every 10th European person is not able to neutralize hyperhomocysteinemia effectively. Again it is a very unexpected result because in general the gene mutations are rare but the point is that this enzyme deficiency caused by this gene polymorphism can explain only 20% of NTDs. But now we can protect 90%, and therefore it means that practice comes before the science.
Dr. Bates: I was very interested, I think it was Dr. Seller's observation, that there are some vitamin B 12 abnormalities of metabolism in some of the people who have had a NTD, and I think this certainly endorses your view that perhaps vitamin B 12 has not been sufficiently investigated for the possibility that it is responsible for some of the effects of the multivitamins and it certainly should be looked at now. I don't think there have been any investigations as to whether vitamin B 12 on its own would prevent NTDs.
Dr. Czeizel: As far as I know the Dublin group [6] was first and later Mills et al. [7] showed that vitamin B 12 is an independent risk factor in the origin of hyperhomocysteinemia-related NTDs. This association has a theoretical explanation because methionine synthase is a vitamin B 12 -dependent enzyme.
Dr. Bates: My question was about the effect of increased twining. It was suggested that possibly the increased number of twins might be a problem in so far as the prognosis for twin development can be poorer than that of singletons. If this is the case this is something that needs to be looked at in a population such as yours where a fortification has now been introduced, whether there are any deleterious effects.
Dr. Czeizel: It is a very important point because Lumley et al. [8] in Australia stated that the benefit in connection with the prevention of NTDs was neutralized with the risk of multiple pregnancies. I don't agree because Lumley et al. used the data of multiple pregnancies from the 1970s when multiple pregnancies were mainly diagnosed very near to the end of the pregnancy, but now we have ultrasound scanning during pregnancy and in general multiple pregnancies are diagnosed in the first or second trimester. After this there is appropriate special antenatal care, and it can significantly reduce the higher perinatal morbidity and mortality observed earlier.
First we found a 40% increase in multiple pregnancies [9] in our randomized controlled trial. In our second two-cohort controlled intervention study we found an increase in multiple pregnancies in Budapest but not in the countryside. It is interesting because in the countryside in China there was no increase in twins pregnancies after the periconceptional use of 0.4 mg folic acid [10] , but a US [11] and a Swedish study [12] , in very industrialized countries, confirmed our result. It is a sensitive point, however, as far as I know, there are no data regarding twin pregnancies after food fortification by folic acid.
Dr. Young:
You mentioned the hyperhomocysteinemia that is associated with NTDs. We have talked about the MTHFR genotype. You mentioned B 6 and B 12 . There was a very interesting article in a great issue of the American Journal of Clinical Nutrition, which you might not have had an opportunity to see yet. It was authored by McNulty et al. [13] in collaboration with Dr. Scott in Dublin and they have now introduced riboflavin as an additional cofactor in the determination of homocysteine concentrations.
Dr. Czeizel: Riboflavin is a cofactor of MTHFR. Dr. Young: That is right, and riboflavin status modulates the effect of folate homocysteine levels. So I wonder whether you would now incorporate riboflavin in your multivitamin cocktail?
Dr. Czeizel: Unfortunately I haven't seen this paper [13] , but thank you very much for your information. Our micronutrient combination and bread fortification project contained riboflavin.
Dr. Abu Libdeh: I always had this question in mind since we started talking about the occurrence of NTDs and preventing them by folic acid. How does folic acid prevent the development of NTDs? Is it that these women are usually in a state of folic acid deficiency, and by giving them folic acid this would reduce the risk of developing NTDs, or the excess of folic acid in their blood, and their circulation will facilitate the closure of the neural tube? Would you clarify this please?
Dr. Czeizel: I don't want to correct you but I think there is no folic acid deficiency, folic acid as a tablet from drug stores, because folic acid is a synthetic product. Folate is available in different foods, and I think we may have spoken about folate deficiency. We highlight hyperhomocysteinemia because we know this part of the story relatively well. Hyperhomocysteinemia can inhibit the closure of neural tube while folate/folic acid can neutralize the effect of hyperhomocysteinemia therefore can help the closure of neural tube. It is a typical gene-environment interaction, the primary factor is the low activity of MTHFR due to gene polymorphism and the secondary factor is the folate deficiency in the diet. However, everybody knows that folate/folic acid is also a key factor in DNA synthesis because it is a major carbon donor and I am sure that during organogenesis between the 3rd and 8th postconceptional weeks there is fantastic development with extremely high mitosis activity, and there is a tremendous requirement for this vitamin. In addition, beyond the above-mentioned two possibilities, folate/folic acid may have many other different routes and different targets but now we know only relatively well hyperhomocysteinemia-related birth defects and cardiovascular diseases. However, I am sure that we need other explanations as well.
Dr. Sacy: In medically assisted reproduction or in families with known multiple pregnancies would you recommend increasing the dose of preventive folic acid?
Dr. Czeizel: Yes, we do. I think it is an interesting theoretical idea. I reviewed a paper submitted to the Lancet, and the results of this paper were a great surprise for me, though they were difficult to believe. In the UK an in vitro fertilization clinic used high-dose folic acid during the in vitro fertilization procedure and they were able to significantly increase the success rate. I was later informed that the Lancet refused publication of the paper.
Dr. Sazawal: You talked about the identification of defects, NTDs, cardiovascular and urinary tract, and you used the term where you were looking at infants which were lost during pregnancy, stillbirth and delayed birth. Can you explain a little bit more how the defects were identified? What was the procedure for the identification of defects, and how possible are these procedures in a developing country setting?
Dr. Czeizel: In Hungary all deliveries take place in hospital, autopsy during the infant period is obligatory and it is usual among stillborn fetuses. Malformed children receive intensive pediatric care. There are four obligatory ultrasound scannings during pregnancy and one in the neonatal period. Chromosome analysis is performed in nearly 100% of fetuses in women over the age of 35 years. Thus in general we have a good chance of detecting all structural birth defects. In addition we did a follow-up study of our two intervention trials that were sponsored by Hoffman-La Roche of Switzerland, and the children were followed until the age of 7 years and were examined personally by our experts. The intellectual, behavioral and anthropometrical development as well as the functions of sense organs were checked. To conclude, I am sure that our data on congenital abnormalities are correct.
Dr. Sazawal: My question wasn't that, I was only trying to get an idea of how possible it is to replicate this kind of study in a developing country setting and what changes might be needed from your experience?
Dr. Czeizel: I am sorry that I misunderstood your question. On the one hand I took part in a meeting in Utah some months ago and the idea of possibly organizing a randomized control trial was discussed in connection with the prevention of orofacial clefts. In 1982 Tolarova [14] was the first in Prague to describe the preventive effect of folic acid in recurrent cleft lip; however, she used 10 mg. Our two intervention trials did not confirm her results, but we used a micronutrient combination containing only 0.8 mg folic acid. On the other hand we have a population-based observational study showing that 6 mg folic acid alone reduced the incidence of orofacial clefts by 30% [15] . Therefore it was discussed whether it is possible to organize a new randomized controlled trial to study the different doses of folic acid and make a comparison between folic acid-containing multivitamins. Finally your question was related to developing countries. I was on a WHO mission in the United Arab Emirates and we were able to establish a national registry based on the appropriate level of medical care [16] .
Dr. Al Awar: My question is general. With regard to most of the micronutrients we discussed as daily supplements, and keeping in mind the complaints of the people who take daily supplements, I wonder if there have been any studies done to check or assess whether twice weekly supplements would be beneficial or effective considering the factors of absorption and excretion of excess amounts. I don't know if any studies have been done to assess this. 
